FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2730831592> ?p ?o ?g. }

• W2730831592 endingPage "e697" @default.
• W2730831592 startingPage "e694" @default.
• W2730831592 abstract "Surgical-site infections are one of the most concerning complications in patients treated with growing rods (GR). The purpose of this study was to evaluate the use of preoperative screening for Staphylococcus aureus (SA) for all growing spine procedures, and if this would permit alteration of prophylactic antibiotics to cover the identified resistances.All patients were identified who had SA screening during the course of GR treatment. In otal, 34 patients [23 neuromuscular (NMS), 4 congenital, 4 idiopathic scoliosis (IS), and 3 syndromic] were identified who had 111 preoperative screenings [79 lengthenings, 23 insertions, 6 revisions, and 3 conversions to posterior spinal fusions (PSF)]. Mean age at GR insertion was 5.5 years (2 to 11 y).There were 11 methicillin-resistant Staphylococcus aureus (MRSA) + screenings in 6 patients (5 NMS, 1 IS): 3 in 3 patients before GR insertion and 8 in 3 patients (all 3 were negative at GR insertion screening) at subsequent surgeries. There were 23 methicillin-sensitive Staphylococcus aureus (MSSA) + screenings in 12 patients (7 NMS, 2 congenital, 2 IS, 1 syndromic): 2 in 2 patients before GR insertion and 21 in 10 patients at subsequent surgeries (18 lengthenings, 3 revisions). Overall, 13 patients (3 MRSA+10 MSSA) were initially negative but screened positive for the first time at a subsequent surgery (12 lengthenings, 1 GR to PSF). All patients (n=5) with positive screenings before GR insertion were in patients with NMS (3 MRSA, 2 MSSA). On the basis of sensitivities, 9 patients demonstrated SA resistance to cefazolin (8 MRSA and 1 MSSA) and 6 to clindamycin (5 MRSA and 1 MSSA). Hence, if cefazolin was routinely used for all patients 26.5% of patients (9/34) would have been inadequately covered at some point during their GR treatment; clindamycin, 17.7% (6/34).The use of SA nasal swab screening in GR patients identified 9 patients (26.5%) whose prophylactic antibiotics (cefazolin) could be altered to permit appropriate SA coverage.Level IV-retrospective case series." @default.
• W2730831592 created "2017-07-14" @default.
• W2730831592 creator A5056686116 @default.
• W2730831592 creator A5058963791 @default.
• W2730831592 date "2019-10-01" @default.
• W2730831592 modified "2023-09-25" @default.
• W2730831592 title "Nasal Swab Screening for Staphylococcus aureus in Spinal Deformity Patients Treated With Growing Rods" @default.
• W2730831592 cites W18338975 @default.
• W2730831592 cites W1939512501 @default.
• W2730831592 cites W1996213402 @default.
• W2730831592 cites W2034021585 @default.
• W2730831592 cites W2048444495 @default.
• W2730831592 cites W2053310922 @default.
• W2730831592 cites W2056432907 @default.
• W2730831592 cites W2082339364 @default.
• W2730831592 cites W2087865186 @default.
• W2730831592 cites W2172177019 @default.
• W2730831592 cites W2319780380 @default.
• W2730831592 cites W2322404283 @default.
• W2730831592 cites W2323378418 @default.
• W2730831592 cites W2324471810 @default.
• W2730831592 doi "https://doi.org/10.1097/bpo.0000000000001015" @default.
• W2730831592 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31503226" @default.
• W2730831592 hasPublicationYear "2019" @default.
• W2730831592 type Work @default.
• W2730831592 sameAs 2730831592 @default.
• W2730831592 citedByCount "0" @default.
• W2730831592 crossrefType "journal-article" @default.
• W2730831592 hasAuthorship W2730831592A5056686116 @default.
• W2730831592 hasAuthorship W2730831592A5058963791 @default.
• W2730831592 hasConcept C11701158 @default.
• W2730831592 hasConcept C141071460 @default.
• W2730831592 hasConcept C2777052132 @default.
• W2730831592 hasConcept C2777334864 @default.
• W2730831592 hasConcept C2778353156 @default.
• W2730831592 hasConcept C2779489039 @default.
• W2730831592 hasConcept C2779982284 @default.
• W2730831592 hasConcept C501593827 @default.
• W2730831592 hasConcept C523546767 @default.
• W2730831592 hasConcept C54355233 @default.
• W2730831592 hasConcept C71924100 @default.
• W2730831592 hasConcept C86803240 @default.
• W2730831592 hasConcept C89423630 @default.
• W2730831592 hasConceptScore W2730831592C11701158 @default.
• W2730831592 hasConceptScore W2730831592C141071460 @default.
• W2730831592 hasConceptScore W2730831592C2777052132 @default.
• W2730831592 hasConceptScore W2730831592C2777334864 @default.
• W2730831592 hasConceptScore W2730831592C2778353156 @default.
• W2730831592 hasConceptScore W2730831592C2779489039 @default.
• W2730831592 hasConceptScore W2730831592C2779982284 @default.
• W2730831592 hasConceptScore W2730831592C501593827 @default.
• W2730831592 hasConceptScore W2730831592C523546767 @default.
• W2730831592 hasConceptScore W2730831592C54355233 @default.
• W2730831592 hasConceptScore W2730831592C71924100 @default.
• W2730831592 hasConceptScore W2730831592C86803240 @default.
• W2730831592 hasConceptScore W2730831592C89423630 @default.
• W2730831592 hasIssue "9" @default.
• W2730831592 hasLocation W27308315921 @default.
• W2730831592 hasLocation W27308315922 @default.
• W2730831592 hasOpenAccess W2730831592 @default.
• W2730831592 hasPrimaryLocation W27308315921 @default.
• W2730831592 hasRelatedWork W2010601134 @default.
• W2730831592 hasRelatedWork W2153539422 @default.
• W2730831592 hasRelatedWork W2156396250 @default.
• W2730831592 hasRelatedWork W2286868915 @default.
• W2730831592 hasRelatedWork W2560705238 @default.
• W2730831592 hasRelatedWork W2918578413 @default.
• W2730831592 hasRelatedWork W3133924332 @default.
• W2730831592 hasRelatedWork W3136110650 @default.
• W2730831592 hasRelatedWork W3144929179 @default.
• W2730831592 hasRelatedWork W83817037 @default.
• W2730831592 hasVolume "39" @default.
• W2730831592 isParatext "false" @default.
• W2730831592 isRetracted "false" @default.
• W2730831592 magId "2730831592" @default.
• W2730831592 workType "article" @default.